Past Event Recordings
Engagement Activities
Past Event Recordings
We are committed to engaging the psychiatry research community globally. Through our workshops and events, we strive to bring all aspects of the global research community together to tackle challenges within drug discovery.
Want to co-host an event or workshop with us?
A selection of our online events are available to view below:
A Target Product Profile for an agitation treatment for people living with dementia
18th January 2022 Overview There is a huge unmet need for effective and safe treatments for the symptoms of dementia and Alzheimer’s disease to help patients and carers today and into the future. Investment in research in this area as well as the investment seen in development of disease-modifying treatments […]
Read moreBuilding bridges along the psychiatric drug discovery pipeline #5
This the final instalment of a 5-part webinar series between the British Neuroscience Association and the Psychiatry Consortium. Psychiatric drug discovery must be a truly collaborative process if it is to be successful. All too often industry and academia work exclusively, developing transformative work in isolation of each other and […]
Read moreBuilding bridges along the psychiatric drug discovery pipeline #4
This the fourth instalment of a 5-part webinar series between the British Neuroscience Association and the Psychiatry Consortium. Psychiatric drug discovery must be a truly collaborative process if it is to be successful. All too often industry and academia work exclusively, developing transformative work in isolation of each other and […]
Read moreBuilding bridges along the drug discovery pipeline #1
9 November 2021 This is the first of a collaborative 5-part webinar series between the British Neuroscience Association and the Psychiatry Consortium. Psychiatric drug discovery must be a truly collaborative process if it is to be successful. All too often industry and academia work exclusively, developing transformative work in isolation […]
Read moreBuilding bridges along the psychiatric drug discovery pipeline #2
23 November 2021 Trigger warning: This webinar contains a personal account of mental health struggles, including references to suicide, which some viewers may find distressing. If you are affected by any of the issues raised in this webinar, please visit our partner; MQ Mental Health for resources and support. This is the […]
Read moreBuilding bridges along the psychiatric drug discovery pipeline #3
22 February 2022 This is the third instalment of a 5-part webinar series between the British Neuroscience Association and the Psychiatry Consortium. Psychiatric drug discovery must be a truly collaborative process if it is to be successful. All too often industry and academia work exclusively, developing transformative work in isolation […]
Read moreDelivering the next generation drug discovery pipeline
On 1st May 2020, the Psychiatry Consortium and Psychiatric Genomics Consortium co-hosted a workshop to bring together key opinion leaders and experts from the worlds of pharma, biotech, academia and the charity sector. The workshop aimed to discuss the challenges that arise in the early stages of the psychiatric drug […]
Read moreExploring preclinical models for psychiatric drug discovery
On 25th February 2021, the Psychiatry Consortium, British Pharmacological Society and Laboratory Animal Sciences Association co-hosted a series of seminars and workshops to bring together researchers from a variety of backgrounds and interests to address the translational validity, and future of preclinical models in psychiatric drug discovery. Access a selection […]
Read morePsychopharmacology drug discovery in the 21st century
On 22nd July 2020, in partnership with the British Association of Psychopharmacology, this online event showcased the new approaches taken by academic and biotech groups towards target validation, drug discovery and development in neuroscience. The Changing Neuroscience Drug Discovery Landscape in the UK Presented by Dr Laura Ajram from the […]
Read more
